LLY

714.52

-4.44%↓

JNJ

146.39

-1.44%↓

UNH

308.04

-0.79%↓

ABBV

177.11

-5.79%↓

NVO

64.32

-1.7%↓

LLY

714.52

-4.44%↓

JNJ

146.39

-1.44%↓

UNH

308.04

-0.79%↓

ABBV

177.11

-5.79%↓

NVO

64.32

-1.7%↓

LLY

714.52

-4.44%↓

JNJ

146.39

-1.44%↓

UNH

308.04

-0.79%↓

ABBV

177.11

-5.79%↓

NVO

64.32

-1.7%↓

LLY

714.52

-4.44%↓

JNJ

146.39

-1.44%↓

UNH

308.04

-0.79%↓

ABBV

177.11

-5.79%↓

NVO

64.32

-1.7%↓

LLY

714.52

-4.44%↓

JNJ

146.39

-1.44%↓

UNH

308.04

-0.79%↓

ABBV

177.11

-5.79%↓

NVO

64.32

-1.7%↓

Search

Waters Corp

Slēgts

SektorsVeselības aprūpe

345.72 -3.78

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

345.13

Max

359.29

Galvenie mērījumi

By Trading Economics

Ienākumi

-110M

121M

Pārdošana

-211M

662M

P/E

Sektora vidējais

33.303

56.602

EPS

2.25

Peļņas marža

18.344

Darbinieki

7,600

EBITDA

-193M

152M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+10.5% upside

Dividendes

By Dow Jones

Nākamie ieņēmumi

2025. g. 30. jūl.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-499M

22B

Iepriekšējā atvēršanas cena

349.5

Iepriekšējā slēgšanas cena

345.72

Ziņu noskaņojums

By Acuity

35%

65%

111 / 382 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Strong Bullish Evidence

Waters Corp Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 14. maijs 23:40 UTC

Karstas akcijas

Stocks to Watch: UnitedHealth Group, Foot Locker, CoreWeave

2025. g. 14. maijs 23:33 UTC

Galvenie tirgus virzītāji

UnitedHealth Group Shares Fall After WSJ Reports of Investigation for Possible Medicare Fraud

2025. g. 14. maijs 23:25 UTC

Galvenie tirgus virzītāji

Biohaven Shares Down as FDA Extends PDUFA Data for Troriluzole

2025. g. 14. maijs 23:25 UTC

Peļņas

Xero Lifts Fiscal Year Profit 30% on Higher Prices, Subscriber Growth -- Update

2025. g. 14. maijs 22:58 UTC

Peļņas

Xero Lifts Fiscal Year Profit 30% on Higher Prices, Subscriber Growth

2025. g. 14. maijs 21:35 UTC

Peļņas

Cisco Systems Names Patterson as CFO, Patel as President

2025. g. 14. maijs 23:59 UTC

Tirgus saruna

Implications of Xero's Cost Outlook Aren't Clear -- Market Talk

2025. g. 14. maijs 23:49 UTC

Tirgus saruna

Xero's Cost Outlook Likely to Prompt Downgrades -- Market Talk

2025. g. 14. maijs 23:48 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 14. maijs 23:48 UTC

Tirgus saruna

Nikkei May Decline on Profit-Taking After Recent Gains -- Market Talk

2025. g. 14. maijs 23:47 UTC

Tirgus saruna

Gold Gains on Possible Technical Recovery -- Market Talk

2025. g. 14. maijs 23:34 UTC

Iegādes, apvienošanās, pārņemšana

Agnico-Eagle Mines to Subscribe for 30M Voting Common Shares of Foran Mining in Non-Brokered Private Placement at C$3 a Share

2025. g. 14. maijs 23:10 UTC

Peļņas

Xero Lifts FY Profit 30% on Higher Prices, Subscriber Growth -- Update

2025. g. 14. maijs 23:07 UTC

Peļņas

CoreWeave Posts Strong Revenue and Wins Google as a Customer. Stock Still Dives on Outlook. -- Barrons.com

2025. g. 14. maijs 23:00 UTC

Top Ziņas

UnitedHealth Group Is Under Criminal Investigation for Possible Medicare Fraud -- WSJ

2025. g. 14. maijs 22:43 UTC

Peļņas

Xero Lifts FY Profit 30% on Higher Prices, Subscriber Growth

2025. g. 14. maijs 22:34 UTC

Peļņas

Xero Expects 1H Operating Expense Ratio to Be Higher Than 2H>XRO.AU

2025. g. 14. maijs 22:33 UTC

Peļņas

Xero Expects FY26 Operating Expense Ratio of 71.5%>XRO.AU

2025. g. 14. maijs 22:30 UTC

Peļņas

Xero Did Not Declare a Dividend>XRO.AU

2025. g. 14. maijs 22:30 UTC

Peļņas

Xero FY Operating Expenses 71.8% of Operating Revenue Vs. 73.3%>XRO.AU

2025. g. 14. maijs 22:30 UTC

Peļņas

Xero FY Free Cashflow Margin 24.1% Vs. 20.0%>XRO.AU

2025. g. 14. maijs 22:30 UTC

Peļņas

Xero FY Free Cashflow NZD506.7M Vs. NZD342.1M>XRO.AU

2025. g. 14. maijs 22:28 UTC

Peļņas

Xero FY Ebitda NZD638.5M Vs. NZD497.4M>XRO.AU

2025. g. 14. maijs 22:28 UTC

Peļņas

Xero FY Adjusted Ebitda NZD640.6M Vs. NZD526.5M>XRO.AU

2025. g. 14. maijs 22:27 UTC

Peļņas

Xero FY Rev NZD2.10B Vs. NZD1.71B >XRO.AU

2025. g. 14. maijs 22:27 UTC

Peļņas

Xero FY Net NZD227.8M Vs. Net NZD174.6M >XRO.AU

2025. g. 14. maijs 22:23 UTC

Top Ziņas

Boeing, GE Aerospace Get Qatar Airways Order After Saudi AI Tech Deals -- 2nd Update

2025. g. 14. maijs 22:15 UTC

Peļņas

Correction to Cisco Earnings Article -- WSJ

2025. g. 14. maijs 21:48 UTC

Peļņas

CoreWeave Posts Strong Revenue but Stock Dives on Updated Outlook -- Barrons.com

2025. g. 14. maijs 21:37 UTC

Peļņas

Cisco Reports Solid Earnings. The Stock Is Rising. -- Barrons.com

Salīdzinājums

Cenas izmaiņa

Waters Corp Prognoze

Cenas mērķis

By TipRanks

10.5% augšup

Prognoze 12 mēnešiem

Vidējais 396.71 USD  10.5%

Augstākais 460 USD

Zemākais 350 USD

Pamatojoties uz 14 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Waters Corp — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

14 ratings

7

Pirkt

7

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

345.22 / 351.01Atbalsts un pretestība

Īstermiņā

Strong Bullish Evidence

Vidējā termiņā

Bearish Evidence

Ilgtermiņā

Bearish Evidence

Noskaņojums

By Acuity

111 / 382 Rangs Veselības aprūpe

Ziņu noskaņojums

Liecība "Buļļu" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Virs vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Waters Corp

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.